FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
27 letters match. Newest first.
-
DrugsRonanRx, Inc. dba RonanRx
FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsWalmart, Inc.
Walmart sold three unapproved drugs for genital herpes and sores on walmart.com, FDA says.
High risk -
DrugsThe Platinum Healthcare LLC
The Platinum Healthcare LLC sells unapproved new drugs 'Sycosis' and 'Syphillinum' online for STIs, FDA warns.
High risk -
DrugsAidance Scientific, Inc.
FDA: Aidance Scientific's Terragen HG Formula, sold for genital sores, is an unapproved new drug.
High risk -
DrugsOrganiCare, LLC / OrganiCare Nature’s Science, LLC
FDA told OrganiCare of Austin, Texas that its HClear for him and FemiClear Genital Herpes Symptoms ointments are unapproved new drugs.
High risk -
DrugsDesBio/Deseret Biologicals, Inc.
FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.
High risk -
DrugsIndiangoods.shop
FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.
Medium -
DrugsWholesale Peptide
FDA warns Wholesale Peptide that its website sells Prostamax and Gonadorelin as unapproved new drugs.
High risk -
DrugsTexinkart Inc.
Texinkart Inc. sold four Ayurvedic products online without FDA drug approval, FDA says.
High risk -
DrugsNativeMed LLC dba NativeMed
FDA warned telehealth seller NativeMed that its website misbranded compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsGlow Medispa, LLC dba Mint Med
FDA warns telehealth seller Mint Med that its website labels falsely suggest it compounds the semaglutide and tirzepatide drugs it sells.
Low -
DrugsD&H Medical Services
FDA warned D&H Medical Services that its website falsely suggests its compounded semaglutide and tirzepatide are the same as FDA-approved brand drugs.
Low -
DrugsOrderlyMeds LLC dba OrderlyMeds
FDA warned OrderlyMeds over website claims for compounded semaglutide and tirzepatide, saying its labels and 'FDA-licensed pharmacy' claim are misleading.
Low -
DrugsJoi and Blokes dba Joi + Blokes
FDA warned telehealth seller Joi + Blokes that its website misbrands compounded semaglutide and tirzepatide with false, misleading claims.
Medium -
DrugsClover Meds LLC dba Clover Meds
Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.
Medium -
AnimalRidley USA Inc.
Ridley USA's Iowa City medicated feed plant put monensin into cattle feed instead of the intended drug, killing at least 16 cattle.
High risk -
DrugsMile High Compounds LLC
FDA warned Mile High Compounds that it sells unapproved injectable GLP-1-like drugs and BAC water online.
High risk -
DrugsWeightless Medical LLC dba WeightCare
FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.
Low -
DrugsViv Health, Inc. dba VIV RX
FDA warned telehealth company VIV RX that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.
Medium -
DrugsIvim Services LLC dba Ivim
FDA says Ivim's telehealth website mislabels compounded semaglutide and tirzepatide as Ivim-made when it is not the compounder.
Low -
DrugsMaxLife Technologies Inc. dba Maxlife
FDA told telehealth seller Maxlife its website falsely implied Maxlife compounds semaglutide and tirzepatide and that the drugs are FDA-approved.
Medium -
DrugsBetter Health Labs, Inc. dba Measured
FDA warned telehealth seller Measured its website misbranded compounded semaglutide and tirzepatide by implying it made them and that they were FDA-approved.
Medium -
DrugsMEDVi, LLC dba MEDVi
FDA says telehealth seller MEDVi misbranded compounded semaglutide and tirzepatide by implying MEDVi makes them and that they are FDA-approved.
Medium -
DrugsNewman Clinic, PLLC dba Newman Clinic
FDA told Newman Clinic its website misbranded compounded semaglutide and tirzepatide with false and misleading claims.
Medium -
DrugsBliv Wellness LLC dba Bliv
FDA warns Bliv Wellness that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.
Medium -
DrugsBeach Weekend Management LLC dba Nic and Jet Fuel
FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.
Medium -
DevicesPalamur Biosciences Private Limited
FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.
High risk